Quadria Capital
General
Grapevine: TVS Credit, Avendus, Haldiram, Aragen, Yotta in news
Another investor has joined the race to buy KKR's stake in Avendus, while a top US-based private equity firm is ......
General
Grapevine: Zepto, Quadria, TPG, Mensa Brands in news
Quick commerce startup Zepto is in talks to raise $100-150 million (Rs 840-1,260 crore) from domestic family offices and high-net-worth individuals at ......
General
Grapevine: Aragen Life, Urban Company investors weigh stake sale
Promoters and investors in Aragen Life Sciences, the Goldman Sachs-backed contract research organisation (CRO), plan to sell a 10% stake in a ......
Healthcare
PE firms mull buying stake in Apex Hospitals as existing backer seeks exit
Rajasthan-based Apex Hospitals Pvt. Ltd is being evaluated by multiple private equity players for a potential stake buy, as current ......
General
Grapevine: MUFG to step up India play; Quadria to finish Fund I exit by year-end
MUFG Bank aims to accelerate its investments in India, where it has over $10 billion (Rs 83,898 crore) in exposure, including ......
Manufacturing
Kedaara, Quadria in talks to pick up stake in botanical extracts maker
Kedaara Capital and Quadria Capital are among a clutch of private equity firms in the race to pick up a ......
General
Grapevine: Zydus joins Torrent in race for JB Chemicals; The New Shop eyes 24Seven
Torrent Pharmaceuticals and Zydus Lifesciences are vying for control of JB Chemicals and Pharmaceuticals, alongside private equity firm EQT, a media report said. VCCircle previously reported that Torrent Pharma is in ......
Healthcare
Can Quadria Capital meet benchmark in partial exit from India healthcare bet?
Singapore- and Delhi-based private equity firm Quadria Capital, which aims to raise up to $1 billion for its latest fund ......
Healthcare
Quadria Capital mulls another exit from India portfolio
Healthcare-focused private equity firm Quadria Capital is planning to offload its stake in an India portfolio company that it backed ......
Healthcare
Quadria, PremjiInvest-backed firms move a step closer to public float
Quadria-backed drugmaker Akums Drugs & Pharmaceuticals Ltd and PremjiInvest-backed float glass maker Gold Plus have received markets regulator SEBI’s nod ......